We are looking for young people 2 to 17 years old to join a clinical research to help us discover more about treating moderately to severely active IBD. If you are looking for a potential new treatment option for moderately to severely active IBD or CD (including associated symptoms such as weight loss, fistula, bloody stool, weight loss and/or joint pain), consider one of our research studies. All eligible participants will receive no-cost study-related care and study medication. Your young people 2 to 17 years old may be eligible to take part.
Your child may be eligible to take part in the research studies if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
Enrollment is limited, so please respond now.
